Characterization of the human neutrophil alloantigen-3a

Area of Science:

• Immunology
• Genetics
• Transfusion Medicine

Background:

• Transfusion-related acute lung injury (TRALI) is a significant cause of illness and death associated with blood transfusions.
• Severe TRALI cases are frequently attributed to antibodies targeting the human neutrophil alloantigen-3a (HNA-3a) found in blood components.

Purpose of the Study:

• To identify the molecular basis of the HNA-3a antigen.
• To understand the genetic variation responsible for HNA-3a antigen expression.
• To provide a foundation for developing diagnostic tools to mitigate TRALI risk.

Main Methods:

• Analysis of nucleotide polymorphisms within the choline transporter-like protein-2 gene (SLC44A2).
• Correlating specific amino acid variations at position 154 with HNA-3a antigen reactivity.
• Investigating the role of the arginine variant at amino acid position 154 in HNA-3a antigen formation.

Main Results:

• The HNA-3a antigen is determined by a nucleotide polymorphism in the SLC44A2 gene.
• A specific variant at amino acid position 154 (arginine instead of glutamine) defines the HNA-3a antigen.
• This molecular identification clarifies the basis of HNA-3a antigenicity.

Conclusions:

• The molecular identification of the HNA-3a antigen provides critical insight into TRALI pathogenesis.
• Understanding the genetic basis of HNA-3a facilitates the development of targeted screening assays for blood donors.
• Implementing such assays can significantly reduce the incidence of TRALI, improving transfusion safety.